Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
about
Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreakSingle versus combination intravenous antibiotic therapy for people with cystic fibrosisOnce-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisOnce-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisOnce-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisSingle versus combination intravenous antibiotic therapy for people with cystic fibrosisCharacterization of Pseudomonas aeruginosa isolated from chronically infected children with cystic fibrosis in India.Treatments for preventing recurrence of infection withPseudomonas aeruginosain people with cystic fibrosisCarbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the PuzzlePseudomonas aeruginosa Genomic Structure and DiversityNewly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosaPseudomonas aeruginosa population structure revisited.Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain.Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain.Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional studyPseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatmentThe changing microbial epidemiology in cystic fibrosis.Impact of Pseudomonas aeruginosa genomic instability on the application of typing methods for chronic cystic fibrosis infectionsEvolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis cloneSafety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients.Genomic analysis and temperature-dependent transcriptome profiles of the rhizosphere originating strain Pseudomonas aeruginosa M18.Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypesProteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-associated strainSingle versus combination intravenous antibiotic therapy for people with cystic fibrosis.Carbapenem-resistant enterobacteriaceae: an emerging problem in children.Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa.Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosisClinical significance of microbial infection and adaptation in cystic fibrosis.Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients.Systematic reviews and lifelong diseases.Contaminated mouth swabs caused a multi-hospital outbreak of Pseudomonas aeruginosa infection.Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients.Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional studyThe Effect of Sub-MIC β-Lactam Antibiotic Exposure of Pseudomonas aeruginosa Strains from People with Cystic Fibrosis in a Desiccation Survival Model.Pseudomonas and all that.Lung infections. 3. Pseudomonas aeruginosa and other related species.Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa.Infection control in cystic fibrosis.Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients.
P2860
Q22306482-50294B32-9DB8-447F-A017-D73B839E05C1Q24194967-C214C3B8-4B78-42D8-AE0B-212867758DCBQ24200604-2544F354-D12D-4553-9DE5-A6E3266EE637Q24203710-AC1D620C-49B2-4918-AF9E-B11EA50ECDBBQ24241057-F24DC07E-C208-4151-914E-27F5BDF72134Q24244134-4A03F1FE-437A-4E0B-AE52-094F953BF700Q24810743-BA5A5E0F-3075-4DDA-A9A7-975FC802089DQ26470661-3EE9804E-D477-40C5-9852-3FA53B5AC6A4Q28078925-D1F5D3CC-FD12-41F7-8681-D480EDA6EEB3Q28244678-72B12B0A-617E-4F99-849A-ABCA560F2502Q28492507-1CE545FE-69A0-4FDF-AE98-7772195289E1Q30913394-006E98A2-4565-44CD-B6EB-6E70D156021BQ33214091-3A29D260-EFA4-4D7A-86EF-BC63603A8F97Q33285539-D1E8390A-39E4-48B4-929F-D1DCB8E71F4AQ33801253-BDB80EF3-F008-4FDF-9E04-15D9B2434F95Q33824149-E0E93DD5-71DC-44D4-B456-5967729774A1Q33825634-58C4D8B8-EACD-4BB0-925E-DD488351E0F2Q33909400-801C8E8C-4F54-42B1-AD21-2F711D2DF1BEQ33911762-9871486A-FA0A-4E10-929E-C66B2F43D576Q33926652-20F188D2-CEA0-41C3-8CCC-BDCCF30825F2Q33963695-FFF749C6-4A56-4E3D-8AE8-CF5531AC79EFQ34007844-8B4FC36A-FAD1-4D8C-8F90-562A8A7AAEF1Q34067203-069A739D-62D6-40EA-8003-A65FB3EBE480Q34134628-E1D1500A-6BE9-49AA-A736-DF4D0A1B2A48Q34202477-03C865AB-14D7-4AD6-90DB-4D10454B3203Q34281727-32E3AFEB-B4F5-4203-9841-8FCB50BE33F3Q34418832-9D20AA57-3CC1-4487-B624-DF36581FC152Q34487493-4B753A18-C43C-4CA8-9A86-5891B0A37B66Q34491552-0AB7240C-CEFD-40A0-A3D5-2BDCDFC8C7D1Q34565049-0BA2166B-BBE3-43A9-B0E4-442D66349218Q34787080-950DEE55-A485-4B85-8682-C2D877233210Q34886882-BFE9004C-6BB0-42D2-A1AB-9BDE510AD5BFQ35088182-214D5BAE-2450-4AF8-8222-A48E61C87173Q35178544-ACD2EDD8-467A-46CD-8634-0EB7D81C8941Q35250893-22EC042F-955A-4667-AB4A-D8EE856729B8Q35263901-C763337C-510A-41E5-82F1-8990C96F6823Q35532283-45C8619D-4049-4964-9626-7AC2239F6748Q35534898-DD8DAC92-C8AE-42DD-B87B-7CD48A9EA815Q35545544-E0A2EF2C-1506-4CB9-B426-CD9342726413Q35573139-A8CE1BBE-585F-4766-9F84-11ABE0F17C28
P2860
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
@en
type
label
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
@en
prefLabel
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
@en
P2093
P1433
P1476
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic
@en
P2093
H van Saene
P304
P356
10.1016/S0140-6736(96)05169-0
P407
P577
1996-09-01T00:00:00Z